Two new clinical trials to develop treatments to prevent people catching (coronavirus) COVID-19 are to launch in the UK.
Hundreds of thousands of the UK’s most vulnerable people could be set to benefit from innovative treatments that stop them catching COVID-19, as 2 new government-funded clinical trials launch in the UK.
The trials will test the effectiveness of treatments - which have already shown promising early results for treating COVID-19, in preventing the virus and therefore its transmission among care home residents and those with weakened immune systems, such as transplant patients or those on dialysis.
Any treatment proven to be safe and effective will be rapidly made more widely available on the NHS, and will mean people for whom COVID-19 vaccines may be less effective due to their lowered immune systems - such as cancer patients - will have additional protection to prevent infection and serious illness.
The PROTECT-V trial, run by the University of Cambridge, will look at potential COVID-19 treatments’ effectiveness in reducing the spread of the virus amongst immunocompromised groups. It launched this month and will last at least 12 months.
There are at least 500,000 people who could benefit from these treatments in England alone, and 2,250 are expected to take part in the clinical trial.
The PROTECT-CH trial, run by the University of Nottingham, will also look at treatments for reducing transmission and serious illness from the virus, for care homes, their residents and staff. The trial will begin in May 2021 and last around 2 years.
It aims to recruit more than 400 care homes to take part, covering approximately 12,000 elderly residents, with any approved treatments having the potential to be rolled out to the 420,000 care home residents across the UK.
For more information visit: GOV.UK
Published March 20 2021
Breakthrough research led by Addenbrooke's Hospital gives IBS patients like Laura Tebbs a better understanding of their condition.
Restoration of sight from a rare genetic mutation may now become a reality thanks to a prestigious award from the National Institute for Health Research (…
An artificial pancreas could soon help people living with type 2 diabetes and who also require kidney dialysis.